RG
Ramilaben Ghemarbhai Chaudhari
About Ramilaben Ghemarbhai Chaudhari
Data last updated:
Ramilaben Ghemarbhai Chaudhari is a Director at Harsiddhi Overseas Private Limited (since 2021), Designated Partner at Banas Cancer And Research Institute Llp (since 2026) and Director at Akshar Pathology Laboratory Private Limited (since 2023), and holds 2 more current directorships. The companies operate in Trading and Healthcare. The largest current company by reported revenue is Harsiddhi Overseas Private Limited at ₹9.02 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Jul 2021 | 2021 | ₹9.02 Cr (FY 2024) | Active | |
| Designated Partner | 09 Feb 2026 | 2026 | Active | ||
| Director | 05 Sep 2023 | 2023 | Active | ||
| Designated Partner | 08 Jun 2022 | 2022 | Active | ||
| Director | 02 Jul 2018 | 2018 | Active |
Board colleagues of Ramilaben Ghemarbhai Chaudhari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ghemarbhai Kanjibhai Chaudhari | 09252134 | Harsiddhi Overseas Private Limited , Akshar Pathology Laboratory Private Limited and 1 more | Director |
| Mohitkumar Himmatlal Nakrani | 09252135 | Harsiddhi Overseas Private Limited | Director |
| Geeta Itesh Khatwani | 11535317 | Banas Cancer And Research Institute Llp | Designated Partner |
| Maniben Ghemarbhai Chaudhary | 11535315 | Banas Cancer And Research Institute Llp | Designated Partner |
| Mukeshkumar Prahladji Chaudhary | 10063505 | Banas Cancer And Research Institute Llp | Designated Partner |
| Rati Rushabh Kothari | 11535318 | Banas Cancer And Research Institute Llp | Designated Partner |
| Shreya Gaurang Modi | 11535316 | Banas Cancer And Research Institute Llp | Designated Partner |
| Alihusain Noormohmmed Maknojiya | 08171062 | Rensat Pharma Private Limited | Director |
| Jainish Acharya Bharatbhai | 07962042 | Rensat Pharma Private Limited | Director |
| Maheshbhai Acharya Dalpatbhai | 07960746 | Rensat Pharma Private Limited | Director |
| Sonal Hiteshkumar Dave | 08171131 | Rensat Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramilaben Ghemarbhai Chaudhari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramilaben Ghemarbhai Chaudhari
Ramilaben Ghemarbhai Chaudhari currently holds 5 directorships: Harsiddhi Overseas Private Limited (Director, since 23 Jul 2021, revenue ₹9.02 Cr (FY 2024)); Banas Cancer And Research Institute Llp (Designated Partner, since 09 Feb 2026); Akshar Pathology Laboratory Private Limited (Director, since 05 Sep 2023); Adarsh Path Labs Llp (Designated Partner, since 08 Jun 2022); Rensat Pharma Private Limited (Director, since 02 Jul 2018).
Ramilaben Ghemarbhai Chaudhari was first appointed on 02 Jul 2018 as Director at Rensat Pharma Private Limited. The most recent appointment on record is 09 Feb 2026 at Banas Cancer And Research Institute Llp.
The current boards of Ramilaben Ghemarbhai Chaudhari's companies include Ghemarbhai Kanjibhai Chaudhari (Harsiddhi Overseas Private Limited), Mohitkumar Himmatlal Nakrani (Harsiddhi Overseas Private Limited), Geeta Itesh Khatwani (Banas Cancer And Research Institute Llp), Maniben Ghemarbhai Chaudhary (Banas Cancer And Research Institute Llp), Mukeshkumar Prahladji Chaudhary (Banas Cancer And Research Institute Llp), Rati Rushabh Kothari (Banas Cancer And Research Institute Llp), among others.